As of April 24, 2025, RxSight (RXST) has a market cap of $0.59 billion USD. According to our data, RxSight is ranked No.5795 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 24, 2025 | $0.59 B |
-57.58%
|
Dec 31, 2024 | $1.39 B |
-14.73%
|
Dec 29, 2023 | $1.63 B |
218.23%
|
Dec 30, 2022 | $0.51 B |
12.62%
|
Dec 31, 2021 | $0.45 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Alcon
ALC
|
$46.44 B |
89.671 M
|
![]() Switzerland
|
![]() Bausch + Lomb
BLCO
|
$4.50 B |
-0.000 M
|
![]() Canada
|
![]() STAAR Surgical
STAA
|
$0.86 B |
0.000 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$374.44 B |
0.003 M
|
![]() USA
|
![]() Hoya
7741.T
|
$38.57 B |
0.227 B
|
![]() Japan
|
![]() EssilorLuxottica
EL.PA
|
$129.33 B |
-3.299 B
|
![]() France
|
![]() Cooper Companies
COO
|
$16.16 B |
0.001 M
|
![]() USA
|
![]() Novartis
NVS
|
$218.37 B |
1.248 B
|
![]() Switzerland
|
![]() Santen Pharmaceutical
4536.T
|
$3.38 B |
-9.528 M
|
![]() Japan
|
![]() Glaukos
GKOS
|
$5.29 B |
-0.000 M
|
![]() USA
|
![]() Ocular Therapeutix
OCUL
|
$1.25 B |
0.000 M
|
![]() USA
|
![]() EyePoint Pharmaceuticals
EYPT
|
$0.46 B |
-0.000 M
|
![]() USA
|
![]() LENSAR
LNSR
|
$0.16 B |
-0.000 M
|
![]() USA
|
Market Cap | = | RXST Stock Price | * | RXST Shares Outstanding |
= | $14.47 | * | 40.62 M | |
= | $0.59 B |